Paper7775615
Teicoplanin or vancomycin in the treatment of gram-positive infections?
Murphy S and 1 other. J Clin Pharm Ther, 1995. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Teicoplanin or vancomycin in the treatment of gram-positive infections? Papers, record 7775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7775615
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gram-Positive Bacteria | Major topic |
| Gram-Positive Bacterial Infections | Major topic |
| Teicoplanin | Major topic |
| Vancomycin | Major topic |
| Cell Wall | |
| Cost-Benefit Analysis | |
| Drug Resistance, Microbial | |
| Half-Life | |
| Humans |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39846780 | Population pharmacokinetic analysis of teicoplanin in paediatric patients, including those receiving continuous kidney replacement therapy: a prospective cohort study. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/39846780 | PubMed |
| 37633977 | Drug-drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports. | Sci Rep | 2023 | https://conductscience.org/library/papers/37633977 | PubMed |
| 34505824 | Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes. | Appl Environ Microbiol | 2021 | https://conductscience.org/library/papers/34505824 | PubMed |
| 24624183 | The use of natural biopolymer of chitosan as biodegradable beads for local antibiotic delivery: release studies. | Jundishapur J Nat Pharm Prod | 2013 | https://conductscience.org/library/papers/24624183 | PubMed |
| 18803030 | Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital. | Pharm World Sci | 2008 | https://conductscience.org/library/papers/18803030 | PubMed |
| 10164059 | Rational prescribing of antibacterials in hospitalised children. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10164059 | PubMed |
| 9849051 | [Febrile neutropenia: practical aspects]. | Med Klin (Munich) | 1998 | https://conductscience.org/library/papers/9849051 | PubMed |
| 9505828 | Current approach to postoperative endophthalmitis. | Br J Ophthalmol | 1997 | https://conductscience.org/library/papers/9505828 | PubMed |
| 9474472 | Pharmacokinetics of drugs used in critically ill adults. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9474472 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7775615
GET https://conductscience.org/api/papers/v1/7775615/authors